{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-118109","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2026-11-10T22:15:38+00:00","discovered_at":"2026-11-10T22:18:00.254900+00:00","generated_at":"2026-11-10T22:18:06.047802+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"medium","headline":"CorMedix to acquire substantially all Heron Therapeutics assets, adding four FDA-approved brands including ZYNRELEF","bullets":["CorMedix entered a definitive asset purchase agreement to buy substantially all of Heron Therapeutics' assets; deal announced November 9, 2026, with a Pharmakon term loan facility involved in funding.","Consideration includes CorMedix common stock issued to Heron in a private placement; Heron stockholders must vote on the transaction; earn-out milestones and royalty payments are contemplated.","Acquired portfolio is described as four FDA-approved commercial brands, including ZYNRELEF, expected to diversify revenue and be accretive to earnings.","Closing conditioned on Heron stockholder approval and required regulatory clearances; the agreement includes a termination fee payable by Heron in specified circumstances.","No purchase price, per-share value or premium is disclosed in the filed text; continued separate payment for ZYNRELEF under the NOPAIN Act is cited as a revenue driver."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-118109","json":"https://secwatch.observer/filing/0001213900-26-118109.json","markdown":"https://secwatch.observer/filing/0001213900-26-118109.md","text":"https://secwatch.observer/filing/0001213900-26-118109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026118109/0001213900-26-118109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026118109/ea0311532-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T22:18:06.047802+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}